Literature DB >> 19135060

Molecular composition and functional properties of f-channels in murine embryonic stem cell-derived pacemaker cells.

Andrea Barbuti1, Alessia Crespi, Daniela Capilupo, Nausicaa Mazzocchi, Mirko Baruscotti, Dario DiFrancesco.   

Abstract

Mouse embryonic stem cells (mESCs) differentiate into all cardiac phenotypes, and thus represent an important potential source for cardiac regenerative therapies. Here we characterize the molecular composition and functional properties of "funny" (f-) channels in mESC-derived pacemaker cells. Following differentiation, a fraction of mESC-derived myocytes exhibited action potentials characterized by a slow diastolic depolarization and expressed the I(f) current. I(f) plays an important role in the pacemaking mechanism of these cells since ivabradine (3 microM), a specific f-channel inhibitor, inhibited I(f) by about 50% and slowed rate by about 25%. Analysis of I(f) kinetics revealed the presence of two populations of cells, one expressing a fast- and one a slow-activating I(f); the two components are present both at early and late stages of differentiation and had also distinct activation curves. Immunofluorescence analysis revealed that HCN1 and HCN4 are the only isoforms of the pacemaker channel expressed in these cells. Rhythmic cells responded to beta-adrenergic and muscarinic agonists: isoproterenol (1 microM) accelerated and acetylcholine (0.1 microM) slowed spontaneous rate by about 50 and 12%, respectively. The same agonists caused quantitatively different effects on I(f): isoproterenol shifted activation curves by about 5.9 and 2.7 mV and acetylcholine by -4.0 and -2.0 mV in slow and fast I(f)-activating cells, respectively. Accordingly, beta1- and beta2-adrenergic, and M2-muscarinic receptors were detected in mESC-derived myocytes. Our data show that mESC-derived pacemaker cells functionally express proteins which underlie generation and modulation of heart rhythm, and can therefore represent a potential cell substrate for the generation of biological pacemakers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19135060     DOI: 10.1016/j.yjmcc.2008.12.001

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  13 in total

1.  I(f) and SR Ca(2+) release both contribute to pacemaker activity in canine sinoatrial node cells.

Authors:  Zhan Gao; Biyi Chen; Mei-Ling A Joiner; Yuejin Wu; Xiaoqun Guan; Olha M Koval; Ashok K Chaudhary; Shane R Cunha; Peter J Mohler; James B Martins; Long-Sheng Song; Mark E Anderson
Journal:  J Mol Cell Cardiol       Date:  2010-04-07       Impact factor: 5.000

2.  Generation of murine cardiac pacemaker cell aggregates based on ES-cell-programming in combination with Myh6-promoter-selection.

Authors:  Christian Rimmbach; Julia J Jung; Robert David
Journal:  J Vis Exp       Date:  2015-02-17       Impact factor: 1.355

3.  SK4 Ca2+ activated K+ channel is a critical player in cardiac pacemaker derived from human embryonic stem cells.

Authors:  David Weisbrod; Asher Peretz; Anna Ziskind; Nataly Menaker; Shimrit Oz; Lili Barad; Sivan Eliyahu; Joseph Itskovitz-Eldor; Nathan Dascal; Daniel Khananshvili; Ofer Binah; Bernard Attali
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

4.  Anacardic acid and thyroid hormone enhance cardiomyocytes production from undifferentiated mouse ES cells along functionally distinct pathways.

Authors:  Agnese Re; Simona Nanni; Aurora Aiello; Serena Granata; Claudia Colussi; Giulia Campostrini; Francesco Spallotta; Stefania Mattiussi; Valentina Pantisano; Carmen D'Angelo; Annamaria Biroccio; Alessandra Rossini; Andrea Barbuti; Dario DiFrancesco; Francesco Trimarchi; Alfredo Pontecorvi; Carlo Gaetano; Antonella Farsetti
Journal:  Endocrine       Date:  2015-11-07       Impact factor: 3.633

5.  Distinct expression patterns of HCN channels in HL-1 cardiomyocytes.

Authors:  Anne Günther; Arnd Baumann
Journal:  BMC Cell Biol       Date:  2015-07-04       Impact factor: 4.241

6.  A detailed characterization of the hyperpolarization-activated "funny" current (If) in human-induced pluripotent stem cell (iPSC)-derived cardiomyocytes with pacemaker activity.

Authors:  Federica Giannetti; Patrizia Benzoni; Giulia Campostrini; Raffaella Milanesi; Annalisa Bucchi; Mirko Baruscotti; Patrizia Dell'Era; Alessandra Rossini; Andrea Barbuti
Journal:  Pflugers Arch       Date:  2021-05-02       Impact factor: 3.657

7.  In vitro epigenetic reprogramming of human cardiac mesenchymal stromal cells into functionally competent cardiovascular precursors.

Authors:  Matteo Vecellio; Viviana Meraviglia; Simona Nanni; Andrea Barbuti; Angela Scavone; Dario DiFrancesco; Antonella Farsetti; Giulio Pompilio; Gualtiero I Colombo; Maurizio C Capogrossi; Carlo Gaetano; Alessandra Rossini
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

8.  Enhancement of Spontaneous Activity by HCN4 Overexpression in Mouse Embryonic Stem Cell-Derived Cardiomyocytes - A Possible Biological Pacemaker.

Authors:  Yukihiro Saito; Kazufumi Nakamura; Masashi Yoshida; Hiroki Sugiyama; Tohru Ohe; Junko Kurokawa; Tetsushi Furukawa; Makoto Takano; Satoshi Nagase; Hiroshi Morita; Kengo F Kusano; Hiroshi Ito
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

9.  Programming and isolation of highly pure physiologically and pharmacologically functional sinus-nodal bodies from pluripotent stem cells.

Authors:  Julia Jeannine Jung; Britta Husse; Christian Rimmbach; Stefan Krebs; Juliane Stieber; Gustav Steinhoff; Andreas Dendorfer; Wolfgang-Michael Franz; Robert David
Journal:  Stem Cell Reports       Date:  2014-04-17       Impact factor: 7.765

10.  The Interaction between Adult Cardiac Fibroblasts and Embryonic Stem Cell-Derived Cardiomyocytes Leads to Proarrhythmic Changes in In Vitro Cocultures.

Authors:  Jan Trieschmann; Daniel Bettin; Moritz Haustein; Annette Köster; Marek Molcanyi; Marcel Halbach; Mira Hanna; Mariam Fouad; Konrad Brockmeier; Jürgen Hescheler; Kurt Pfannkuche; Tobias Hannes
Journal:  Stem Cells Int       Date:  2016-01-05       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.